Effect of topical alkane vapocoolant spray on pain with intravenous cannulation in patients in emergency departments: randomised double blind placebo controlled trial

Ramzi Hijazi, David Taylor, Joanna Richardson, Ramzi Hijazi, David Taylor, Joanna Richardson

Abstract

Objective: To assess the efficacy, acceptability, and safety of a topical alkane vapocoolant in reducing pain during intravenous cannulation in adults.

Design: Randomised double blind placebo controlled trial.

Setting: Emergency department of a metropolitan teaching hospital.

Participants: 201 adult patients (54% male), mean (SD) age 58.2 (19.5) years, who required intravenous cannulation.

Interventions: Less than 15 seconds before cannulation, the skin area was sprayed with either water (control, n=98) or vapocoolant (intervention, n=103), from a distance of 12 cm for 2 seconds. The intervention spray was a blend of propane, butane, and pentane.

Main outcome measures: Pain with cannulation and discomfort with spray, measured with a 100 mm visual analogue scale.

Results: Groups did not differ significantly in age, sex, indication for or site of cannulation, cannula size, or who cannulated the patient (P>0.05). Median (interquartile range) pain scores for cannulation in the control and intervention groups were 36 (19-51) and 12 (5-40) mm, respectively (P<0.001), and 59 (60%) and 33 (32%) reported pain scores >or=30 mm (P<0.001). Scores for spray discomfort also differed significantly (P<0.001) because of skewing to the right within the intervention group. The median discomfort scores, however, were 0 mm in both groups. Success rates for first cannulation attempt did not differ between groups (P=0.39). Thirty four (39%) and 62 (62%) patients said they would choose the spray they received for analgesia in the future (P=0.002). At follow-up at five days, two patients in the intervention group reported transient skin redness.

Conclusions: Topical alkane vapocoolant spray is effective, acceptable, and safe in reducing pain with peripheral intravenous cannulation in adults in the emergency department.

Trial registration: Australian Clinical Trials ACTRN12607000470493.

Conflict of interest statement

Competing interests: None declared.

Figures

https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4787502/bin/hijr593129.f1.jpg
Fig 1 Recruitment and flow of participants though trial
https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4787502/bin/hijr593129.f2.jpg
Fig 2 Distribution of pain scores with cannulation

References

    1. Biro P, Meier T, Cummins AS. Comparison of topical anaesthesia methods for venous cannulation in adults. Eur J Pain 1997;1:37-42.
    1. Selby IR, Bowles BJ. Analgesia for venous cannulation: a comparison of EMLA (5 minutes application), lignocaine, ethyl chloride, and nothing. J R Soc Med 1995;88:264-7.
    1. Armstrong P, Young C, McKeown D. Ethyl chloride and venepuncture pain: a comparison with intradermal lidocaine. Can J Anaesth 1990;37:656-8.
    1. Norris WD. The use of local anaesthesia in peripheral venous cannulation: current practice of junior doctors. J R Nav Med Serv 2002;88:62-4.
    1. Todd KH, Funk JP. The minimum clinically important difference in physician-assigned visual analog pain scores. Acad Emerg Med 1996;3:142-6.
    1. Young B, Heath JW. Wheater’s functional histology. 4th ed. London: Churchill Livingstone, 2002.
    1. Habif TP. Clinical dermatology. 4th ed. Edinburgh: Mosby, 2004.
    1. Ehrenstrom-Reiz G, Reiz S, Stockman O. Topical anaesthesia with EMLA, a new lidocaine-prilocaine cream and the Cusum technique for detection of minimal application time. Acta Anaesthesiol Scand 1983;27:510-2.
    1. Smith and Nephew Healthcare. Ametop. St Laurent, QC: Smith and Nephew Healthcare, 1996.
    1. Sado DM, Deakin CD. Local anaesthesia for venous cannulation and arterial blood gas sampling: are doctors using it? J R Soc Med 2005;98:158-60.
    1. Reis EC, Jacobson RM, Tarbell S, Weniger BG.. Taking the sting out of shots: control of vaccination-associated pain and adverse reactions. Pediatr Ann 1998;27:375-86.
    1. Hartstein BH, Barry JD. Mitigation of pain during intravenous catheter placement using a topical skin coolant in the emergency department. Emerg Med J 2008;25:257-61.
    1. Berthier F, Potel G, Leconte P, Touze M, Baron D. Comparative study of methods of measuring acute pain intensity in an ED. Am J Emerg Med 1998;16:132-6.
    1. Rosier EM, Iadarola MJ, Coghill RC. Reproducibility of pain measurement and pain perception. Pain 2002;98:205-16.
    1. Kelly AM. Does the clinically significant difference in visual analog scale pain scores vary with gender, age, or cause of pain? Acad Emerg Med 1998;5:1086-90.
    1. Kelly AM. The minimum clinically significant difference in visual analogue scale pain score does not differ with severity of pain. Emerg Med J 2001;18:205-7.
    1. Todd KH, Funk KG, Funk JP, Bonacci R. Clinical significance of reported changes in pain severity. Ann Emerg Med 1996;27:485-9.
    1. Browne J, Awad I, Plant R, McAdoo J, Shorten G. Topical amethocaine (Ametop (TM)) is superior to EMLA for intravenous cannulation. Can J Anaesth 1999;46:1014-8.
    1. Bjerring P, Andersen PH, Arendtnielsen L. Vascular response of human skin after analgesia with EMLA cream. Br J Anaesth 1989;63:655-60.
    1. Harris T, Cameron PA, Ugoni A. The use of pre-cannulation local anaesthetic and factors affecting pain perception in the emergency department setting. Emerg Med J 2001;18:175-7.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi